Exploring Serum Biomarker Levels in Tetralogy of Fallot, Hypoplastic Left Heart Syndrome, and Healthy Children
Pediatric Cardiology · 2026
DOI: 10.1007/s00246-025-03935-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Cardiology, 2026. Verfasst von Ariel Vargas und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Tetralogy of Fallot, Hypoplastic Left Heart Syndrome. Die Arbeit nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Serum biomarkers have emerged as tools for diagnosis and management in adult heart disease but are less investigated in the pediatric population. This exploratory study reports biomarker profiles in unrepaired tetralogy of Fallot (TOF), repaired TOF (rTOF), hypoplastic left heart syndrome (HLHS) following Fontan surgery, and healthy controls. We compared circulating biomarker patterns between TOF, rTOF, HLHS, and control groups, aiming to characterize potential disease-specific profiles and generate hypotheses for future research. We prospectively enrolled subjects and collected single-time blood samples for analysis. We measured: microRNA-21 (miR-21), soluble suppression of tumorigenicity-2 (sST-2), galectin-3 (Gal-3), procollagen type-I carboxy-terminal pro-peptide (PICP), procollagen type-III amino-terminal pro-peptide (PIIINP), metalloproteinases (MMP-1/MMP-9), and NT-proBNP. We included 207 patients: TOF ( n = 75), rTOF ( n = 60), HLHS ( n = 11), and healthy controls ( n = 60). Compared to the younger controls, TOF patients had higher PICP, MMP-1, and NT-proBNP. Compared to older controls, rTOF patients had higher PIIINP, MMP-1, MMP-9, and NT-proBNP; and HLHS patients had higher PIIINP and MMP-1. Collagen metabolism biomarkers and MMP-1 were elevated across disease groups. Gal-3 was associated with age in HLHS. No disease-specific patterns were observed; however, differences from controls suggest cardiac remodeling in TOF and HLHS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
- Atrium Health Levine Children's Hospital, Charlotte, NC, USA.
- Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
- Philadelphia College of Osteopathic Medicine, Philadelphia, PA, USA.
- Dana-Farber Cancer Institute, New York City, NY, USA.
- Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, PA, USA. mercerrosal@chop.edu.
Zitieren
APA
Vargas, A., Galan, J., Reddy, K., Thomas, A., Hughes, N., DeCost, G., Mai, A. D., Jones, A. L., Gardner, M. M., & Mercer-Rosa, L. (2026). Exploring Serum Biomarker Levels in Tetralogy of Fallot, Hypoplastic Left Heart Syndrome, and Healthy Children. Pediatric Cardiology. https://doi.org/10.1007/s00246-025-03935-0
Vancouver
Vargas A, Galan J, Reddy K, Thomas A, Hughes N, DeCost G, et al. Exploring Serum Biomarker Levels in Tetralogy of Fallot, Hypoplastic Left Heart Syndrome, and Healthy Children. Pediatric Cardiology. 2026. doi:10.1007/s00246-025-03935-0
BibTeX
@article{Vargas2026,
author = {Vargas, Ariel and Galan, Jose and Reddy, Kriyana and Thomas, Angeli and Hughes, Nkecha and DeCost, Grace and Mai, Anh D and Jones, Andrea L and Gardner, Monique M and Mercer-Rosa, Laura},
title = {Exploring Serum Biomarker Levels in Tetralogy of Fallot, Hypoplastic Left Heart Syndrome, and Healthy Children},
journal = {Pediatric Cardiology},
year = {2026},
doi = {10.1007/s00246-025-03935-0}
}
EUVIMED